Clinical trial
A Pilot Study of Effects of Exenatide on Body Weight in Non-Diabetic, Obese Patients
NCT00500370 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Study of Effects of Exenatide on Body Weight in Non-Diabetic, Obese Patients
- Lead sponsor
- AstraZeneca
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 30, 2007
- Completion date
- February 29, 2008
- Enrollment
- 163 (actual)
- Sites
- 16
Conditions
As the registry lists them; a condition with its own page is linked.